The General Assembly of the European Association for the Study of the Liver (EASL) has elected new members to its Governing Board, various committees and a new Editor-In-Chief for its Journal of Hepatology. 12 April 2019 - Vienna, Austria The…
Before the advent of antiretroviral drugs, the prognosis for patients with AIDS was extremely poor. However, new antiretroviral treatments have revolutionised care for patients with HIV/AIDS, making lifelong viral suppression possible and improving life expectancy to near normal in patients…
Liver cancer is a leading cause of cancer death, with hepatocellular carcinoma (HCC) accounting for 85–90% of all primary liver cancers. In a recent issue of Journal of Hepatology, Dr Baumeister et al. showed that higher total physical activity was…
SCIENTIFIC PRESS RELEASE Developing personalised targets for treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) Barcelona, Spain - An EU Horizon 2020-financed project investigating methods to better understand the role of the microbiome to help stratify patient health care and…
Alcoholic liver disease and nonalcoholic fatty liver disease (NAFLD) are the leading etiologies for chronic liver disease chronic-liver-disease-related deaths in the United States over the last decade, according to the results of a new study. The prevalence of nonalcoholic fatty…
Perspectum Diagnostics released details regarding the latest version of its LiverMultiScan magnetic resonance imaging technology which identified nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, according to a press release. The latest version of LiverMultiScan, known as LiverMultiScan IDEAL, will feature…
As of January 2018 the Specialty Certificate Examination (SCE) in Gastroenterology and the European Section and Board of Gastroenterology and Hepatology Examination (ESBGHE), have been replaced by the European Specialty Examination in Gastroenterology and Hepatology (ESEGH). The ESEGH is a…
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers at the University of Colorado Anschutz…
San Francisco — Patients with non-alcoholic fatty liver disease carried a 91% higher risk for malignancy and the risk for cancer with obesity is “driven by NAFLD,” according to a presentation at The Liver Meeting 2018. “The risk of malignancy…
Study finds fatty liver disease is less likely to occur in mothers who breastfeed for more than six months. Researchers at UC San Diego School of Medicine and Kaiser Permanente have discovered that mothers who breastfed a child or children…